These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 7847397

  • 1. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended.
    Am J Hosp Pharm; 1994 Oct 01; 51(19):2326. PubMed ID: 7847397
    [No Abstract] [Full Text] [Related]

  • 2. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Jul 22; 43(28):505-9. PubMed ID: 8022396
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP, Traineau R, Tuveri R, Ravera N, Bureau C, Gluckman E, Benbunan M, Loiseau P.
    Bone Marrow Transplant; 1996 Dec 22; 18(6):1131-3. PubMed ID: 8971383
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C and immune globulin.
    López-Jiménez J, Odriozola J, Pérez-Oteyza J, García-Laraña J.
    N Engl J Med; 1995 May 04; 332(18):1235-6. PubMed ID: 7700324
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C and immune globulin.
    Prince AM, Horowitz B.
    N Engl J Med; 1995 May 04; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis C and immune globulin.
    Douglas SD, Slade HB.
    N Engl J Med; 1995 May 04; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transmission of viral infections through intravenous immune globulin.
    Schiff RI.
    N Engl J Med; 1994 Dec 15; 331(24):1649-50. PubMed ID: 7969346
    [No Abstract] [Full Text] [Related]

  • 13. Experimental experience with virus validation studies.
    Willkommen H.
    Dev Biol Stand; 1996 Dec 15; 88():317-8. PubMed ID: 9119155
    [No Abstract] [Full Text] [Related]

  • 14. Gammagard and reported hepatitis C virus episodes.
    Gomperts ED.
    Clin Ther; 1996 Dec 15; 18 Suppl B():3-8. PubMed ID: 8930438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Side-effects of intravenous immune globulins.
    Duhem C, Dicato MA, Ries F.
    Clin Exp Immunol; 1994 Jul 15; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [Abstract] [Full Text] [Related]

  • 19. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
    Razvi S, Schneider L, Jonas MM, Cunningham-Rundles C.
    Clin Immunol; 2001 Dec 15; 101(3):284-8. PubMed ID: 11726220
    [Abstract] [Full Text] [Related]

  • 20. Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board.
    Yap PL.
    Ir Med J; 1997 Dec 15; 90(3):84, 86, 88. PubMed ID: 9183082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.